NR1H4 and primary biliary cholangitis: Out of the total number of clinical trials listed, 12 studies used FXR agonist alone or in combination with either a fibrate such as benzafibrate or with ursodeoxycholic acid (UDCA), to treat biliary and cholestatic related conditions, and PBC in particular (Table 2).